Fig. 7

Anti-endometriosis performance of BSA-GOx-NPs. A Schematic drawing of treatment with PBS, BSA-NPs or BSA-GOx-NPs, starting from the acute inflammatory phase of endometriosis. B, C. Images B and total volume C of endometriotic lesions in mice following different treatments starting from the acute inflammatory phase of endometriosis. N = 9 per group. D Fluorescence images of TUNEL staining in endometriotic lesions in mice following different treatments starting from the acute inflammatory phase of endometriosis. Blue staining is DAPI, green staining is TUNEL. Scale bar is 50 μm. E Monitoring the body weight of mice receiving different treatments starting from the acute inflammatory phase of endometriosis. F Schematic drawing of treatment with PBS, BSA-NPs or BSA-GOx-NPs, starting from the chronic inflammatory phase of endometriosis. G, H Images G and total volume H of endometriotic lesions in mice following different treatments starting from the chronic inflammatory phase of endometriosis. N = 6 per group. I Fluorescence images of TUNEL staining in endometriotic lesions in mice following different treatments starting from the chronic inflammatory phase of endometriosis. Blue staining is DAPI, green staining is TUNEL. Scale bar is 50 μm. J Monitoring the body weight of mice receiving different treatments starting from the chronic inflammatory phase of endometriosis. Data are shown as mean ± SEM and analyzed by one-way ANOVA with Turkey’s post hoc test or two-tailed t-test. *P < 0.05, **P < 0.01